Meta-analysis of the prognostic value of circulating tumor cells in breast cancer
- PMID: 22908097
- DOI: 10.1158/1078-0432.CCR-12-1587
Meta-analysis of the prognostic value of circulating tumor cells in breast cancer
Abstract
Purpose: The prognostic value of circulating tumor cells (CTC) detected in breast cancer patients is currently under debate. Different time points of blood collections and various CTC assays have been used in the past decades. Here, we conducted the first comprehensive meta-analysis of published literature on the prognostic relevance of CTC, including patients with early and advanced disease.
Experimental design: A comprehensive search for articles published between January 1990 and January 2012 was conducted; reviews of each study were conducted and data were extracted. The main outcomes analyzed were overall survival (OS) and disease-free survival (DFS) in early-stage breast cancer patients, as well as progression-free survival (PFS) and OS in metastatic breast cancer patients. Pooled hazard ratio (HR) and 95% confidence intervals (CIs) were calculated using the random and the fixed-effects models. Subgroup and sensitivity analyses were also conducted.
Results: Forty-nine eligible studies enrolling 6,825 patients were identified. The presence of CTC was significantly associated with shorter survival in the total population. The prognostic value of CTC was significant in both early (DFS: HR, 2.86; 95% CI, 2.19-3.75; OS: HR, 2.78; 95% CI, 2.22-3.48) and metastatic breast cancer (PFS: HR, 1.78; 95% CI, 1.52-2.09; OS: HR, 2.33; 95% CI, 2.09-2.60). Further subgroup analyses showed that our results were stable irrespective of the CTC detection method and time point of blood withdrawal.
Conclusion: Our present meta-analysis indicates that the detection of CTC is a stable prognosticator in patients with early-stage and metastatic breast cancer. Further studies are required to explore the clinical utility of CTC in breast cancer.
©2012 AACR
Similar articles
-
Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.BMC Cancer. 2023 Dec 12;23(1):1224. doi: 10.1186/s12885-023-11711-7. BMC Cancer. 2023. PMID: 38087278 Free PMC article.
-
Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.JAMA Netw Open. 2020 Nov 2;3(11):e2026921. doi: 10.1001/jamanetworkopen.2020.26921. JAMA Netw Open. 2020. PMID: 33211112 Free PMC article.
-
Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.BMC Cancer. 2017 Nov 7;17(1):725. doi: 10.1186/s12885-017-3704-8. BMC Cancer. 2017. PMID: 29115932 Free PMC article. Review.
-
Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer.Ann Oncol. 2015 Mar;26(3):535-41. doi: 10.1093/annonc/mdu568. Epub 2014 Dec 15. Ann Oncol. 2015. PMID: 25515656
-
The significant prognostic value of circulating tumor cells in triple-negative breast cancer: a meta-analysis.Oncotarget. 2016 Jun 14;7(24):37361-37369. doi: 10.18632/oncotarget.8156. Oncotarget. 2016. PMID: 27008698 Free PMC article. Review.
Cited by
-
Preclinical and Clinical Evaluation of Magnetic-Activated Cell Separation Technology for CTC Isolation in Breast Cancer.Front Oncol. 2020 Sep 15;10:554554. doi: 10.3389/fonc.2020.554554. eCollection 2020. Front Oncol. 2020. PMID: 33042837 Free PMC article.
-
Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer.Br J Cancer. 2013 Jun 25;108(12):2426-32. doi: 10.1038/bjc.2013.265. Epub 2013 Jun 11. Br J Cancer. 2013. PMID: 23756869 Free PMC article. Review.
-
Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood.Cell Mol Bioeng. 2015;8(1):137-150. doi: 10.1007/s12195-015-0381-z. Epub 2015 Feb 24. Cell Mol Bioeng. 2015. PMID: 25798204 Free PMC article.
-
Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis.Front Oncol. 2019 Nov 26;9:1222. doi: 10.3389/fonc.2019.01222. eCollection 2019. Front Oncol. 2019. PMID: 31850190 Free PMC article.
-
Nanotechnology in Radiation Oncology.Hematol Oncol Clin North Am. 2019 Dec;33(6):1071-1093. doi: 10.1016/j.hoc.2019.08.002. Epub 2019 Oct 1. Hematol Oncol Clin North Am. 2019. PMID: 31668207 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous